Page 58 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY

ADULT-ONSET ASTHMA – PREDICTORS OF CLINICAL COURSE AND SEVERITY
REFERENCES
1. Amelink M, De Groot JC, De Nijs SB, Lu er R, Zwinderman AH, Sterk PJ, et al. Severe adult-onset asthma: A dis nct phenotype. Journal of Allergy and Clinical Immunology 2013; 132.
2. Simpson JL, Sco R, Boyle MJ, Gibson PG. In ammatory subtypes in asthma: Assessment and iden - ca on using induced sputum. Respirology 2006; 11:54-61.
3. Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ, et al. Tailored interven ons based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database of Systema c Reviews 2007.
4. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. E ects of steroid therapy on in ammatory cell subtypes in asthma. Thorax 2010; 65.
5. Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, et al. Pathological features and inhaled cor costeroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62:1043-9.
6. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. Interna onal ERS/ATS guidelines on de ni on, evalua on and treatment of severe asthma. European Respiratory Journal, 2014:343-73.
7. Pavord ID, Bafadhel M. Exhaled nitric oxide and blood eosinophilia: Independent markers of preventable risk. Journal of Allergy and Clinical Immunology 2013; 132:828-9.
8. Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide concentra on to iden fy eosinophilic airway in amma on: an observa onal study in adults with asthma. Clinical and Experimental Allergy 2005; 35:1175-9.
9. Schleich FN, Seidel L, Sele J, Manise M, Quaedvlieg V, Michils A, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count >= 3% in a cohort of unselected pa ents with asthma. Thorax 2010; 65:1039-44.
10. Has e AT, Moore WC, Li HS, Rector BM, Ortega VE, Pascual RM, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthma c subjects. Journal of Allergy and Clinical Immunology 2013; 132:72-U150.
11. Schleich FN, Manise M, Sele J, Henket M, Seidel L, Louis R. Distribu on of sputum cellular phenotype in a large asthma cohort: predic ng factors for eosinophilic vs neutrophilic in amma on. Bmc Pulmonary Medicine 2013; 13.
12. Schleich FN, Chevremont A, Paulus V, Henket M, Manise M, Seidel L, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J 2014.
13. Cohn L, Woodru PG. Update in asthma 2013. Am J Respir Crit Care Med 2014; 189:1487-93.
14. Brusselle GG, Maes T, Bracke KR. Eosinophilic airway in amma on in nonallergic asthma. Nature Medicine 2013; 19:977-9.
15. Thomson NC, Chaudhuri R, Heaney LG, Bucknall C, Niven RM, Brightling CE, et al. Clinical outcomes and in ammatory biomarkers in current smokers and exsmokers with severe asthma. Journal of Allergy and Clinical Immunology 2013; 131:1008-16.
16. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic cor costeroid unresponsive asthma. Lancet 1999; 353:2213-4.
17. Lemiere C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, et al. Airway in amma on assessed by invasive and noninvasive means in severe asthma: Eosinophilic and noneosinophilic phenotypes. Journal of Allergy and Clinical Immunology 2006; 118:1033-9.
18. Amelink M, de Nijs SB, de Groot JC, van Tilburg PMB, van Spiegel PI, Krouwels FH, et al. Three phenotypes of adult-onset asthma. Allergy 2013; 68:674-80.
56